Cargando…

Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy

Ex vivo gene therapy based on CD34(+) hematopoietic stem cells (HSCs) has shown promising results in clinical trials, but genetic engineering to high levels and in large scale remains challenging. We devised a sorting strategy that captures more than 90% of HSC activity in less than 10% of mobilized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zonari, Erika, Desantis, Giacomo, Petrillo, Carolina, Boccalatte, Francesco E., Lidonnici, Maria Rosa, Kajaste-Rudnitski, Anna, Aiuti, Alessandro, Ferrari, Giuliana, Naldini, Luigi, Gentner, Bernhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390102/ https://www.ncbi.nlm.nih.gov/pubmed/28330619 http://dx.doi.org/10.1016/j.stemcr.2017.02.010

Ejemplares similares

Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cells
por: Piras, Francesco, et al.
Publicado: (2017)

Assessing the Impact of Cyclosporin A on Lentiviral Transduction and Preservation of Human Hematopoietic Stem Cells in Clinically Relevant Ex Vivo Gene Therapy Settings
por: Petrillo, Carolina, et al.
Publicado: (2019)

The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy
por: Naldini, Luigi, et al.
Publicado: (2022)

Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem Cells
por: Petrillo, Carolina, et al.
Publicado: (2018)

P1373: UNCOVERING UPSIDES AND PITFALLS OF BASE AND PRIME EDITING IN HEMATOPOIETIC STEM CELLS
por: Fiumara, Martina, et al.
Publicado: (2023)

Expanded circulating hematopoietic stem/ progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis
por: Capo, Valentina, et al.
Publicado: (2020)

A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders
por: Tucci, Francesca, et al.
Publicado: (2022)

Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking
por: Ferrari, Samuele, et al.
Publicado: (2020)

Antiviral immunity and nucleic acid sensing in haematopoietic stem cell gene engineering
por: Piras, Francesco, et al.
Publicado: (2020)

Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells from Umbilical Cord Blood
por: Sotnezova, E.V., et al.
Publicado: (2016)

Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches
por: Fraldi, Alessandro, et al.
Publicado: (2018)

Wnt3a nanodisks promote ex vivo expansion of hematopoietic stem and progenitor cells
por: Lalefar, Nahal R., et al.
Publicado: (2016)

Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced Ex Vivo and In Vivo Genetic Engineering
por: Soldi, Monica, et al.
Publicado: (2020)

NOTCH-mediated ex vivo expansion of human hematopoietic stem and progenitor cells by culture under hypoxia
por: Araki, Daisuke, et al.
Publicado: (2021)

S250: UNVEILING THE BIOLOGICAL ROLE OF PERIPHERAL BLOOD HUMAN CIRCULATING HEMATOPOIETIC STEM AND PROGENITOR CELLS
por: Quaranta, Pamela, et al.
Publicado: (2023)

Cord Blood-Derived Hematopoietic Stem/Progenitor Cells: Current Challenges in Engraftment, Infection, and Ex Vivo Expansion
por: Kita, Katsuhiro, et al.
Publicado: (2011)

Tailored Cytokine Optimization for ex vivo Culture Platforms Targeting the Expansion of Human Hematopoietic Stem/Progenitor Cells
por: Branco, André, et al.
Publicado: (2020)

An improved medium formulation for efficient ex vivo gene editing, expansion and engraftment of hematopoietic stem and progenitor cells
por: Rai, Rajeev, et al.
Publicado: (2023)

Gene therapy for ADA‐SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products
por: Aiuti, Alessandro, et al.
Publicado: (2017)

Pandemic Vaccine Preparedness—Have We Left Something Behind?
por: Capua, Ilaria, et al.
Publicado: (2009)

Design of a regulated lentiviral vector for hematopoietic stem cell gene therapy of globoid cell leukodystrophy
por: Ungari, Silvia, et al.
Publicado: (2015)

Successful ex vivo expansion of mouse hematopoietic stem cells
por: Ema, Hideo
Publicado: (2019)

Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia
por: Naldini, Matteo Maria, et al.
Publicado: (2023)

Unique molecular and functional features of extramedullary hematopoietic stem and progenitor cell reservoirs in humans
por: Mende, Nicole, et al.
Publicado: (2022)

S106: LONG-TERM FOLLOW-UP OF BETA-THALASSEMIA PATIENTS TREATED WITH HEMATOPOIETIC STEM CELL GENE THERAPY
por: Marktel, S, et al.
Publicado: (2022)

Protocol to differentiate monolayer human induced pluripotent stem cells into inflammatory responsive astrocytes
por: Giordano, Anna Maria Sole, et al.
Publicado: (2023)

Engineered tumor-infiltrating macrophages as gene delivery vehicles for interferon-α activates immunity and inhibits breast cancer progression
por: Escobar, Giulia, et al.
Publicado: (2014)

Expansion of Human and Murine Hematopoietic Stem and Progenitor Cells Ex Vivo without Genetic Modification Using MYC and Bcl-2 Fusion Proteins
por: Bird, Gregory A., et al.
Publicado: (2014)

Enhanced Ex Vivo Expansion of Human Hematopoietic Progenitors on Native and Spin Coated Acellular Matrices Prepared from Bone Marrow Stromal Cells
por: Wasnik, Samiksha, et al.
Publicado: (2016)

Activation of OCT4 enhances ex vivo expansion of human cord blood hematopoietic stem and progenitor cells by regulating HOXB4 expression
por: Huang, Xinxin, et al.
Publicado: (2015)

Mesenchymal Stromal Cells from Perinatal Tissues as an Alternative for Ex Vivo Expansion of Hematopoietic Progenitor and Stem Cells from Umbilical Cord Blood
por: Bonilla, Ximena, et al.
Publicado: (2023)

Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells
por: Ferrari, Samuele, et al.
Publicado: (2022)

Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series
por: Canarutto, Daniele, et al.
Publicado: (2021)

CH02 peptide promotes ex vivo expansion of umbilical cord blood-derived CD34 (+) hematopoietic stem/progenitor cells : CH02 peptide promotes CD34 (+) UCB-HSPC ex vivo expansion
por: Yang, Yiqi, et al.
Publicado: (2023)

Optimization of ex vivo hematopoietic stem cell expansion in intermittent dynamic cultures
por: Choi, Yong-Soo, et al.
Publicado: (2010)

Hematopoietic stem cells: ex-vivo expansion and therapeutic potential for myocardial ischemia
por: Lu, Jingwei, et al.
Publicado: (2010)

Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells
por: Vavassori, Valentina, et al.
Publicado: (2023)

Hematopoietic progenitor cells and interleukin-stimulated endothelium: expansion and differentiation of myeloid precursors
por: Moldenhauer, Anja, et al.
Publicado: (2008)

The Chemokine SDF-1 Is a Chemoattractant for Human CD34(+) Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34(+) Progenitors to Peripheral Blood
por: Aiuti, A., et al.
Publicado: (1997)

P1392: INTERIM ANALYSIS OF FIRST IN HUMAN PHASE I-II CLINICAL TRIAL OF EX-VIVO GENE THERAPY FOR HURLER SYNDROME: AN UPDATE AT 3 YEAR FOLLOW-UP
por: Tucci, Francesca, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3kjahr8fugdabcq75su41sg6gs